IPSWICH, Mass., Oct. 20, 2015 /PRNewswire/ -- Recognizing the importance of supporting start-up and early-stage biotechnology companies, New England Biolabs® (NEB®) has renewed its commitment of financial and material support for LabCentral, the premiere shared laboratory space in the Boston area. The two companies share a common vision for enabling research and business development through mentorship, and are working together to make this vision a reality.
The support agreement includes details of the goods and services that NEB will provide to LabCentral and LabCentral-resident companies, including 24/7 access to many of NEB's products via its new on-site NEBnow® freezer unit. This automated "kiosk" allows the researchers at LabCentral to advance their studies when they need to, not having to wait for the required laboratory reagents to be shipped and delivered the following day or later.
"Our corporate mission has always been to support life science research, and as a first-of-a-kind shared laboratory space, LabCentral has become a global model in how to create the next generation of powerhouse life science companies. By supporting LabCentral and its resident companies, we're hoping to further support the development of the life sciences community in the Greater Boston Area," explained Andy Bertera, Executive Director of Marketing at NEB. "Many of these companies, with guidance and good science, plus a little good fortune, have the potential to make a mark on the global scene in short order."
In return for the financial and promotional support, LabCentral will allow NEB to conduct scientific presentations, as well as provide technical support to the LabCentral residents, directly at the LabCentral facility. NEB's access to the LabCentral facility will enable NEB to be closer to its customers in the Boston/Cambridge biotech hub, making customer interaction and information exchange possible on a deeper, more personal level.
"We are pleased that NEB has extended its sponsorship of LabCentral, and are excited to have been early users of the NEBnow kiosk," said LabCentral President and Cofounder Johannes Fruehauf, M.D., Ph.D. "Thanks to sponsors like NEB, our residents have access to the latest, most-sophisticated analytical instruments and discovery tools, enabling them to take their research further and faster -- while preserving precious startup dollars."
About New England Biolabs
Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.
About LabCentral (www.labcentral.org; twitter @labcentral)
A 28,000 square-foot facility in the heart of the Kendall Square, Cambridge, biotech innovation hub, LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. It offers fully permitted laboratory and office space for early-stage companies comprising approximately 125 scientists and entrepreneurs. LabCentral provides first-class facility and administrative support, skilled laboratory personnel, a domain-relevant expert speaker series ‒ as well as the other critical services and support that startups need to begin laboratory operations on day one. A private, nonprofit institution, LabCentral was funded in part by a $5 million grant from the Massachusetts Life Sciences Center, with support from its real-estate partner, MIT. Founding sponsors include Triumvirate Environmental and Johnson & Johnson Innovation
NEB®, NEBNOW® and NEW ENGLAND BIOLABS® are registered trademarks of New England Biolabs, Inc.
SOURCE New England Biolabs